FOUNDATION MEDICINE, INC.
BOSTON, MA

Foundation Medicine, Inc., established on October 18, 2012, under Florida company status, is a pioneering leader in the field of comprehensive genomic profiling. Headquartered at 400 Summer St, Boston, MA, with a mailing address in Leon County, DE, Foundation Medicine combines innovative genomic profile products and data services to facilitate improved cancer treatment outcomes. The firm's mission centers on fostering a collaborative culture aimed at enhancing patient care through personalized medical insights. Through its advanced platform, Foundation Medicine examines over 300 genes across all primary classes of genomic alterations, offering critical insights into the genomic makeup of patients' tumors. These insights are integral to helping oncologists match patients with appropriate treatments and expediting the creation of novel therapies. This commitment is further illustrated by testimonies such as that of Christine Bray, an ovarian cancer survivor whose recovery was significantly aided by FoundationOne—a testament to the company's impactful presence at the intersection of medicine and technology. With a diverse portfolio encompassing oncology drugs, diagnostics, data, and technology solutions aimed at streamlining patient care, Foundation Medicine is recognized for its leadership role in genomic profiling. Its operational reach extends across a spectrum of facilities indicated by various contact numbers, from Boston to additional locations including (905) 542-5551 in Toronto. The corporate body comprises key officers such as Sean Dr. Johnston and Dan Malarek serving as directors, with Dominique Schutz managing financial operations. The company's latest annual report recorded on January 9, 2025, underlines its ongoing commitment to innovation and patient support. Further information about Foundation Medicine can be found on their official website at foundationmedicine.com.